Anti-Fas monoclonal antibody Jo2
Alternative Names: Anti-APO-1 monoclonal antibody Jo2Latest Information Update: 17 Jan 2003
At a glance
- Originator Nonindustrial source
- Class Antirheumatics; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 17 Jan 2003 No development reported - Preclinical for Transplant rejection in USA (Injection)
- 01 Nov 1998 Preclinical development for Transplant rejection in USA (Injection)